Evershield: Long-acting, biodegradable implants for local, sustained drug release
B3 Therapeutics: Bypassing the blood brain barrier for the treatment of primary CNS tumors and brain metastases
DNA Self-Activating Warheads (SAWs)
Targeting Non-Tuberculous Mycobacteria with AI-Designed Antimicrobial Peptides
EDDIT: Early Drug Discovery for Targeted Protein Degradation
ChondroNEXT will prevent progression of Osteoarthritis by preventing joint degeneration.
Novel treatment for hypertrophic and keloidal scarring
A new class of selective GSK3B-inhibitors for refractory lymphoid malignancies
Harnessing p53beta as a medical treatment of skin cancer
First in Class Ferroptosis Inhibitors: For Preventative Treatment of Delayed Graft Function in Kidney Transplantation and other Ferroptosis-related indications
